Member Article

Quantum Pharmaceutical Group Promotes Alison Doering to Group Marketing and Communications Head

Alison Doering has been promoted to Head of Group Marketing and Communications at the Quantum Pharmaceutical Group, a leading manufacturer and provider of niche medicines and services to the healthcare sector. Alison, who reports to Group Commercial Director Brian Fisher, joins the Quantum Pharmaceutical Group senior management team from Protomed - an existing business within the Quantum Group responsible for healthcare solution Biodose®.

Alison will lead all brand and corporate marketing and communications for all businesses within the Group, including Quantum Pharmaceutical, UL Medicines, Protomed and Biodose Services.

Commenting on the promotion, Group Commercial Director, Brian Fisher says: “Alison was instrumental in improving the visibility of the Biodose® medicine management dosing system in her previous role. I am delighted that we were able to promote her from within the organisation to this senior role.”

This was posted in Bdaily's Members' News section by Onyx Health Ltd .